Colgate-Palmolive Reports Q3 2026 Earnings, Raises Full-Year EPS Guidance

Colgate-Palmolive (NYSE: CL) Q3 2026 Earnings Summary

On October 30, 2026, Colgate-Palmolive Company filed Form 8-K under Item 2.02 detailing financial results for the third quarter ended September 30, 2026.

Key Financial Metrics

• Net Sales: $5,369 million, an increase of 4.6% compared to $5,131 million in Q3 2025.
• Organic Sales: Up 3.6%, reflecting a 1.7% volume increase and 2.0% pricing gain, offset slightly by a 0.2% drag from lower private label pet food sales.
• GAAP Diluted EPS: $0.94, up 3% year-over-year from $0.91.
• Base Business (Non-GAAP) Diluted EPS: $0.97, up 7% year-over-year from $0.91.
• GAAP Gross Margin: 60.2%, up 80 basis points year-over-year.
• Base Business Gross Margin: 60.3%, up 90 basis points year-over-year.
• Operating Cash Flow: $2,913 million for the first nine months of 2026.

Divisional Highlights

• Latin America: Net sales up 12.5% (organic +6.0%, volume +3.9%, pricing +2.1%, FX +6.5%); operating profit up 17% to $392 million.
• Hill's Pet Nutrition: Net sales up 5.6% (organic +5.7%, volume +1.8%, pricing +3.9%); operating profit up 5% to $267 million.
• Asia Pacific: Net sales up 3.5% (organic +4.6%, volume +1.9%, pricing +2.8%); operating profit down 1% to $211 million.
• Europe, Middle East & Africa: Net sales up 1.4% (organic +2.7%, volume +3.5%, pricing -0.9%); operating profit up 8% to $262 million.
• North America: Net sales decreased 1.7% (organic -1.6%, volume -3.7%, pricing +2.2%); operating profit declined 11% to $177 million.

Updated Full-Year 2026 Guidance

• Net Sales Growth: Narrowed to 4% to 5% (previously 2% to 6%), including a low-single-digit positive FX impact.
• Organic Sales Growth: Broadly in line with nine-month performance (previously 1% to 4%).
• Base Business EPS Growth: Raised to 5% to 7% (previously mid-single-digit growth).
• Gross Margin: Now expected to expand on both GAAP and Base Business terms (previously projected roughly flat).